Skip to main content
Livermore
Livermore
ZHEN

Citadel Advisors LLC

SEC CIK
0001423053
Latest filing
Sep 1, 2026

VRDN holding history

Viridian Therapeutics, Inc. in every 13F filed by Citadel Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VRDN overviewAll 13F holders of VRDNFull Q2 2026 holdings

Shares (Q2 2026)
41,303
Value
$758.7K
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of VRDN by Citadel Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202641,303$758.7K<0.1%−2,276,931−98.2%ReducedHolders
Q1 20262,318,234$45.3M<0.1%+1,638,540+241.1%AddedHolders
Q4 2025679,694$21.2M<0.1%+602,321+778.5%AddedHolders
Q3 202577,373$1.67M<0.1%−572,170−88.1%ReducedHolders
Q2 2025649,543$9.08M<0.1%+560,996+633.6%AddedHolders
Q1 202588,547$1.19M<0.1%−269,811−75.3%ReducedHolders
Q4 2024358,358$6.87M<0.1%+117,091+48.5%AddedHolders
Q3 2024241,267$5.49M<0.1%+196,596+440.1%AddedHolders
Q2 202444,671$581.2K<0.1%−717,740−94.1%ReducedHolders
Q1 2024762,411$13.3M<0.1%−124,230−14.0%ReducedHolders
Q4 2023886,641$19.3M<0.1%+784,210+765.6%AddedHolders
Q3 2023102,431$1.57M<0.1%+16,582+19.3%AddedHolders
Q2 202385,849$2.04M<0.1%+3,794+4.6%AddedHolders
Q1 202382,055$2.09M<0.1%−1,120,263−93.2%ReducedHolders
Q4 20221,202,318$35.1M<0.1%−158,294−11.6%ReducedHolders
Q3 20221,360,612$27.9M<0.1%+428,313+45.9%AddedHolders
Q2 2022932,299$10.8M<0.1%−8,919−0.9%ReducedHolders
Q1 2022941,218$17.4M<0.1%−2,122−0.2%ReducedHolders
Q4 2021943,340$18.6M<0.1%+943,340NewHolders
Q2 20210$00.0%−485,995−100.0%Sold outHolders
Q1 2021485,995$44.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.